Analyst Ratings for AbbVie Inc. (ABBV)Updated: 2017-07-28
Analysts covering AbbVie Inc. (NYSE:ABBV) have given it a consensus rating of Overweight. Last month, ABBV received an average rating of Overweight.
A buy rating was issued by 8 analysts, 2 issued an overweight rating, 12 gave a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Many analysts weighed in on price targets for ABBV. The most optimistic analyst gave a price target of 95, implying potential capital gains of 32.44 percent. The most pessimistic price target was 60, implying potential capital losses of -16.35 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. That number becomes 1.82 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. If we look at the last 90 days instead, we find a net average change of 0.46 percent in FY estimates.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 2 analysts that decreased their estimates. During this time, 2 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 2 analysts that revised their FY estimates downwards.
The growth rate of ABBV's earnings is estimated by analysts to be 41.4 percent. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of ABBV is 0.45.
In the last 52-weeks, ABBV has achieved a high of 75.04 and a low of 55.06. The current market price is above the trailing year's low by 30.28 percent, and 4.41 percent below the high. ABBV has a price/earnings ratio of 18.58. Investors typically compare the P/E ratio to a company's peers in the industry. The ABBV value stock report compares ABBV to some of its peers using value stock charts. The stock has a market capitalization of $115.53 billion. ABBV is estimated to release their earnings results for the quarter on 0000-00-00, days from today.